10159764University College London and GSK plc KTP 25_26 R1ActiveKnowledge Transfer PartnershipInnovate UKTo significantly reduce the analytical time and costs for monoclonal antibodies and complex molecular formats during bioprocess development, using optical analytical technologies. Benefits include safer and more effective medicines at lower costs to patients.